Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study-Reference-Cited by-同舟云学术

Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study

Published:2021-07-23 Issue:7 Volume:54 Page:944-951
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Fumery Mathurin¹^ORCID,Filippi Jérôme²,Abitbol Vered³,Biron Amélie⁴,Laharie David⁵^ORCID,Serrero Melanie⁶,Altwegg Romain⁷,Bouhnik Yoram⁸,Peyrin‐Biroulet Laurent⁹^ORCID,Gilletta Cyrielle¹⁰,Roblin Xavier¹¹^ORCID,Pineton de Chambrun Guillaume⁷,Vuitton Lucine¹²^ORCID,Bourrier Anne³,Nancey Stephane¹³,Gornet Jean‐Marc³,Nahon Stephane¹⁴,Bouguen Guillaume¹⁵^ORCID,Viennot Stephanie¹⁶,Nachury Maria¹⁷,Amiot Aurelien¹⁸^ORCID,Brazier Franck,Yzet Clara,Hebuterne Xavier,Cadiot Guillaume,Brixi Hedia,Rivière Pauline,Poullenot Florian,Treton Xavier,Stefanescu Carmen,Zallot Camille,Beaugerie Laurent,Seksik Philippe,Sokol Harry,Kirchgesner Julien,Boschetti Gilles,Flourié Bernard,Gay Claire,Danion Pauline,Venturin Chloe,Allez Matthieu,Baudry Clotilde,Pariente Benjamin,Wils Pauline,Gagnière Charlotte,Tannoury Jenny

Affiliation:

1. Amiens France

2. Nice France

3. Paris France

4. Reims France

5. Bordeaux France

6. Marseille France

7. Montpellier France

8. Clichy France

9. Nancy France

10. Toulouse France

11. Saint‐Etienne France

12. Besançon France

13. Lyon France

14. Montfermeil France

15. Rennes France

16. Caen France

17. Lille France

18. Creteil France

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16544

Reference20 articles.

1. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

2. Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study

3. Decreasing colectomy rate for ulcerative colitis in the United States between 2007 and 2016: a time trend analysis;Barnes EL;Inflamm Bowel Dis,2020

4. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

5. Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab;Advances in Therapy;2024-08-14

2. Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN;Pediatric Drugs;2024-05-23

3. Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent;Journal of Crohn's and Colitis;2024-05-14

4. Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study;Gastroenterología y Hepatología;2024-05

5. Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2024-04-23